Gaines Jordan, Vgontzas Alexandros N, Fernandez-Mendoza Julio, Kritikou Ilia, Basta Maria, Bixler Edward O
Sleep Research and Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, PA, USA.
Sleep Research and Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine, Hershey, PA, USA.
Brain Behav Immun. 2015 Jul;47:211-7. doi: 10.1016/j.bbi.2014.11.013. Epub 2014 Dec 20.
Over the last 15years, many studies have established an association of sleep apnea with inflammation and metabolic aberrations. However, no controlled studies have examined potential gender effects in this association. We recruited 120 middle-aged, predominantly non-obese mild-to-moderate sleep apneics and controls (62 males, 58 females). All participants underwent a clinical history, physical examination, and 1-night 8-h polysomnography recording and provided a single fasting blood sample for assessment of interleukin-6 (IL-6), tumor necrosis factor receptor 1 (TNFR1), C-reactive protein (CRP), leptin, and adiponectin levels. Among non-sleep apneics, females had higher levels of TNFR1 (p=0.01), CRP (p=0.005), leptin (p<0.001), and adiponectin (p<0.001) compared to males, independent of age and body mass index. When analyzed separately by gender, sleep apneic men had elevated TNFR1 (p=0.04), CRP (p=0.06) and IL-6 (p=0.11) relative to control men; in sleep apneic females, only CRP was elevated (p=0.04). Furthermore, CRP was associated with apnea severity in a dose-response manner (p-linear=0.04 in both genders) and was independently associated with comorbid hypertension in apnea (p-linear=0.005 for women; p-linear=0.09 for men). In conclusion, although women have naturally higher levels of inflammatory and metabolic markers than men, sleep apneic men appear to have a more severe inflammatory profile compared to women. Our findings suggest that these markers should be analyzed and interpreted separately in men and women, and that a single measure of plasma CRP appears to be a clinically-useful marker of apnea severity and comorbid cardiovascular morbidity.
在过去15年里,许多研究证实睡眠呼吸暂停与炎症及代谢异常有关联。然而,尚无对照研究探讨这种关联中潜在的性别差异。我们招募了120名中年、以非肥胖为主的轻至中度睡眠呼吸暂停患者及对照者(62名男性,58名女性)。所有参与者均接受了临床病史采集、体格检查以及为期1晚8小时的多导睡眠图记录,并提供一份空腹血样以评估白细胞介素-6(IL-6)、肿瘤坏死因子受体1(TNFR1)、C反应蛋白(CRP)、瘦素和脂联素水平。在非睡眠呼吸暂停者中,与男性相比,女性的TNFR1(p = 0.01)、CRP(p = 0.005)、瘦素(p < <0.001)和脂联素(p < <0.001)水平更高,且不受年龄和体重指数影响。按性别分别分析时,睡眠呼吸暂停男性的TNFR1(p = 0.04)、CRP(p = 0.06)和IL-6(p = 0.11)相对于对照男性升高;在睡眠呼吸暂停女性中,仅CRP升高(p = 0.04)。此外,CRP与呼吸暂停严重程度呈剂量反应关系(两性的p线性 = 0.04),且在呼吸暂停中与合并高血压独立相关(女性的p线性 = 0.005;男性的p线性 = 0.09)。总之,尽管女性的炎症和代谢标志物水平天然高于男性,但睡眠呼吸暂停男性与女性相比似乎具有更严重的炎症特征。我们的研究结果表明,这些标志物在男性和女性中应分别进行分析和解读,且血浆CRP的单一测量似乎是呼吸暂停严重程度和合并心血管疾病发病率的临床有用标志物。